Open AccessClinical observation of 125I-labeled anti-alpha fetoprotein antibody radioimmunotherapy in hepatocellular carcinoma
Author(s) -
Ying-De Wu,
Ke-Zeng Yang,
De-Nan Zhou,
Y Gang,
Xiangqun Song,
Xiaohua Hu,
Bing-Yan Huang
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v3.i1.43
Subject(s) - radioimmunotherapy , medicine , hepatocellular carcinoma , alpha fetoprotein , gastroenterology , antibody , polyclonal antibodies , survival rate , therapeutic effect , immunology , monoclonal antibody
To observe the therapeutic effects and toxic side effects of (125)I labeled horse anti-human alpha fetoprotein (AFP) polyclonal antibodies in immune targeted therapy against hepatocellular carcinoma (HCC).